These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24187450)

  • 1. Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.
    van Meer S; de Man RA; Siersema PD; van Erpecum KJ
    World J Gastroenterol; 2013 Oct; 19(40):6744-56. PubMed ID: 24187450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.
    Jazag A; Puntsagdulam N; Chinburen J
    Korean J Intern Med; 2012 Jun; 27(2):121-7. PubMed ID: 22707881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: diagnostics and screening.
    Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
    J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
    Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
    Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present and future possibilities for early diagnosis of hepatocellular carcinoma.
    Stefaniuk P; Cianciara J; Wiercinska-Drapalo A
    World J Gastroenterol; 2010 Jan; 16(4):418-24. PubMed ID: 20101765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic management of hepatocellular carcinoma.
    Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
    World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guideline compliant diagnostics of hepatocellular carcinoma].
    Plentz RR; Boozari B; Malek NP
    Radiologe; 2014 Jul; 54(7):660-3. PubMed ID: 24981446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and surveillance for hepatocellular carcinoma: New trends.
    Singal AG; Lampertico P; Nahon P
    J Hepatol; 2020 Feb; 72(2):250-261. PubMed ID: 31954490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R; Lim JK; Patton H; El-Serag HB
    Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
    Kanwal F; Singal AG
    Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
    Demirtas CO; Brunetto MR
    World J Gastroenterol; 2021 Sep; 27(33):5536-5554. PubMed ID: 34588750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality.
    Săndulescu L; Săftoiu A
    Ultraschall Med; 2013 Oct; 34(5):483-4. PubMed ID: 24278973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.